Paragon Genomics Unveils New CleanPlex® Emerging Variant Add-on V2 for Enhanced Identification of Omicron and Emerging SARS-CoV-2 Variants

HAYWARD, Calif.: HAYWARD, Calif., Feb. 22, 2022 /PRNewswire/ -- Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today reported that its CleanPlex® SARS-CoV-2 Research and Surveillance Panels for viral detection, mutation analysis, variant tracking and epidemiological research have continued to play...

Click to view original post